ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study
ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's study of its Parad...
Continue Reading →
